ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,414.99
-0.22%
Dow Jones
39,431.51
-0.21%
Gold vs US Dollar
2,336.29
-1.01%
Brent Oil
83.21
1.00%
Bitcoin
63,009.36
2.54%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Novan Inc (NOVN)

  7. Novan Inc (NOVN) News

Novan (NOVN)

Novan Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NOVN
DateTimeSourceHeadlineSymbolCompany
02/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NOVNNovan Inc
02/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NOVNNovan Inc
02/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NOVNNovan Inc
01/05/202416:49Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
01/05/202416:48Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
01/05/202416:44Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
01/05/202416:41Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
01/05/202416:37Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
25/03/202412:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
26/02/202421:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
30/01/202421:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
26/01/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
05/01/202414:23GlobeNewswire Inc.Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand therapy manufacturing facility in IndianapolisNASDAQ:NOVNNovan Inc
21/12/202321:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
11/12/202300:30GlobeNewswire Inc.Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)NASDAQ:NOVNNovan Inc
08/12/202314:15GlobeNewswire Inc.Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissionsNASDAQ:NOVNNovan Inc
06/12/202300:16GlobeNewswire Inc.Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNHNASDAQ:NOVNNovan Inc
20/11/202306:15GlobeNewswire Inc.Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASHNASDAQ:NOVNNovan Inc
24/10/202322:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
20/10/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
07/09/202321:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
24/08/202321:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
26/07/202321:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
17/07/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
17/07/202314:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
17/07/202313:45GlobeNewswire Inc.Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 ProtectionNASDAQ:NOVNNovan Inc
06/07/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
27/06/202323:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NOVNNovan Inc
16/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NOVNNovan Inc
12/06/202314:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NOVNNovan Inc
 Showing the most relevant articles for your search:NASDAQ:NOVN

Your Recent History

LSE
BIRD
Blackbird
LSE
EEE
Empire Metals
LSE
SYME
Supply@me Capital
LSE
PET
Petrel Resources
LSE
TERN
Tern
LSE
ITV
Itv
LSE
GOLD
LSE
VAST
Vast Resources
LSE
KEFI
Kefi Gold And Copper
LSE
RR.
Rolls-royce
LSE
PANR
Pantheon Resources
LSE
SFOR
S4 Capital
LSE
SAR
Sareum
LSE
GFM
Griffin Mining
LSE
GKP
Gulf Keystone Petroleum
LSE
BOO
Boohoo
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved